Literature DB >> 8374867

Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

J D Roder1, K Böttcher, J R Siewert, R Busch, P Hermanek, H J Meyer.   

Abstract

BACKGROUND: The impact of patient- and tumor-dependent factors and the postoperative course on the prognosis of patients who underwent resection for gastric carcinoma between 1986 and 1989 were analyzed in a prospective multicenter observation study.
METHODS: Resection techniques, the extent of lymph node dissection, and the histopathologic assessment of the specimen were standardized at all participating centers. A total of 1654 patients were enrolled. Follow-up is complete for 99.2% of the patients, with a median follow-up time of 48 months. Prognostic factors were assessed by multivariate analysis.
RESULTS: In the total patient population there was an independent prognostic effect of nodal status, a International Union Against Cancer (UICC)-R0 resection, distant metastases, the pT category, three or more risk factors on preoperative risk analysis, and the presence of postoperative complications. Multivariate analysis in the subgroup of patients who had a UICC-R0 resection confirmed the nodal status as the major independent prognostic factor.
CONCLUSION: These data suggest that the prognosis of patients who undergo gastrectomy for gastric carcinoma may be improved by a complete resection of the primary tumor and its lymphatic drainage, resulting in a UICC-R0 resection. In addition, a detailed preoperative risk analysis and identification of high-risk patients and meticulous attention to the technical details of the surgical procedure to reduce the frequency of postoperative complications may improve the prognosis.

Entities:  

Mesh:

Year:  1993        PMID: 8374867     DOI: 10.1002/1097-0142(19931001)72:7<2089::aid-cncr2820720706>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  77 in total

1.  Intensify standardized therapy for esophageal and stomach cancer in tumor hospitals.

Authors:  S J Wang; D G Wen; J Zhang; X Man; H Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Complications following D3 gastrectomy: post hoc analysis of a randomized trial.

Authors:  Chew-Wun Wu; I-Shou Chang; Su-shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

3.  Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer.

Authors:  A Gil-Rendo; J L Hernández-Lizoain; F Martínez-Regueira; A Sierra Martínez; F Rotellar Sastre; M Cervera Delgado; V Valentí Azcarate; C Pastor Idoate; J Alvarez-Cienfuegos
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

4.  Impact of Combination Criteria of Nodal Counts and Sizes on Preoperative MDCT in Advanced Gastric Cancer.

Authors:  Tsutomu Kawaguchi; Daisuke Ichikawa; Shuhei Komatsu; Toshiyuki Kosuga; Takeshi Kubota; Kazuma Okamoto; Atsushi Shiozaki; Hitoshi Fujiwara; Hirotaka Konishi; Ryo Morimura; Yasutoshi Murayama; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Chouhei Sakakura; Eigo Otsuji
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

5.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

6.  Old and new TNM in carcinoma of the gastric antrum: analysis of our personal experience.

Authors:  Paolo Del Rio; Paolo Dell'Abate; Paolo Soliani; Maria Francesca Arcuri; Sara Tacci; Stefanie Ziegler; Mario Sianesi
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

7.  Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.

Authors:  Markus Menges; Carsten Schmidt; Werner Lindemann; Karsten Ridwelski; Werner Pueschel; Bernhard Jüngling; Gernot Feifel; Martin Schilling; Andreas Stallmach; Martin Zeitz
Journal:  J Cancer Res Clin Oncol       Date:  2003-06-27       Impact factor: 4.553

8.  Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis.

Authors:  Kun Yang; Xin-Zu Chen; Jian-Kun Hu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

Review 9.  Preoperative chemotherapy for unresectable gastric cancer.

Authors:  H Wilke; M Stahl; U Fink; H J Meyer; J R Siewert
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 10.  Staging gastrointestinal cancer as a precondition for multimodal treatment.

Authors:  J R Siewert; A Sendler; H J Dittler; U Fink; H Höfler
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.